• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将反义寡核苷酸与聚乙二醇化碳纳米管缀合可实现 T 淋巴细胞中 PTPN22 的有效敲低。

Conjugation of antisense oligonucleotides to PEGylated carbon nanotubes enables efficient knockdown of PTPN22 in T lymphocytes.

机构信息

Department of Biochemistry and Molecular Biology and Institute for Genetic Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA.

出版信息

Bioconjug Chem. 2009 Mar 18;20(3):427-31. doi: 10.1021/bc800540j.

DOI:10.1021/bc800540j
PMID:19243140
Abstract

PEGylated-carbon nanotubes (PNTs) were evaluated as nanocarriers of antisense oligonucleotides into T-cells using protein tyrosine phosphatase N22 (PTPN22) as a model target gene. PTPN22 is an important predisposing gene and drug target in type 1 diabetes and several other human autoimmune diseases. Here, we generated the first anti-PTPN22 20-mer antisense oligonucleotides (ASOs) and tethered them to PNTs through a cleavable disulfide bond. Spectroscopic and atomic force microscopy analyses were used to determine the loading of ASO onto PNTs, whereas the cleavable nature of the disulfide bond connecting the oligonucleotide to the nanocarrier was confirmed by incubation with dithiothreitol followed by agarose gel electrophoresis. PNT-conjugated ASOs achieved efficient (>50%) knockdown of PTPN22 expression in T-lymphocytes in culture at the mRNA and protein level, as measured by quantitative real-time PCR and Western blotting, respectively. Considering the high biocompatibility and low in vivo toxicity of PNTs, we expect that our approach will be easily translated to achieve in vivo knockdown of PTPN22 and other T lymphocyte targets, thus enabling novel ASO-mediated immunotherapies for type 1 diabetes and other autoimmune diseases.

摘要

聚乙二醇化碳纳米管(PNTs)被评估为将反义寡核苷酸递送到 T 细胞的纳米载体,使用蛋白酪氨酸磷酸酶 N22(PTPN22)作为模型靶基因。PTPN22 是 1 型糖尿病和其他几种人类自身免疫性疾病的重要易感基因和药物靶标。在这里,我们生成了第一个针对 PTPN22 的 20 个碱基对反义寡核苷酸(ASO),并通过可裂解的二硫键将其连接到 PNTs 上。光谱和原子力显微镜分析用于确定 ASO 加载到 PNTs 上的情况,而通过与二硫苏糖醇孵育并进行琼脂糖凝胶电泳来确认连接寡核苷酸和纳米载体的二硫键的可裂解性质。PNT 缀合的 ASO 在培养的 T 淋巴细胞中实现了 PTPN22 表达的高效(>50%)下调,分别通过定量实时 PCR 和 Western 印迹进行测量。考虑到 PNTs 的高生物相容性和低体内毒性,我们预计我们的方法将很容易转化为实现体内 PTPN22 和其他 T 淋巴细胞靶标的下调,从而为 1 型糖尿病和其他自身免疫性疾病提供新的 ASO 介导的免疫疗法。

相似文献

1
Conjugation of antisense oligonucleotides to PEGylated carbon nanotubes enables efficient knockdown of PTPN22 in T lymphocytes.将反义寡核苷酸与聚乙二醇化碳纳米管缀合可实现 T 淋巴细胞中 PTPN22 的有效敲低。
Bioconjug Chem. 2009 Mar 18;20(3):427-31. doi: 10.1021/bc800540j.
2
Use of short interfering RNA delivered by cationic liposomes to enable efficient down-regulation of PTPN22 gene in human T lymphocytes.使用阳离子脂质体递送的短干扰RNA实现人T淋巴细胞中PTPN22基因的有效下调。
PLoS One. 2017 Apr 24;12(4):e0175784. doi: 10.1371/journal.pone.0175784. eCollection 2017.
3
The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3.蛋白酪氨酸磷酸酶非受体22(PTPN22)与成人隐匿性自身免疫性糖尿病患者的谷氨酸脱羧酶抗体高滴度相关:非胰岛素依赖型自身免疫性糖尿病(NIRAD)研究3。
Diabetes Care. 2008 Mar;31(3):534-8. doi: 10.2337/dc07-1457. Epub 2007 Dec 4.
4
Protein tyrosine phosphatase non-receptor type 22 gene variants at position 1858 are associated with type 1 and type 2 diabetes in Estonian population.位于1858位的蛋白酪氨酸磷酸酶非受体22型基因变异与爱沙尼亚人群中的1型和2型糖尿病相关。
Tissue Antigens. 2008 Nov;72(5):425-30. doi: 10.1111/j.1399-0039.2008.01115.x. Epub 2008 Aug 26.
5
A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.一种用于改善反义寡核苷酸细胞递送的新型阴离子树枝状大分子。
J Control Release. 2004 Sep 14;99(1):139-55. doi: 10.1016/j.jconrel.2004.06.009.
6
Protein tyrosine phosphatase PTPN22 in human autoimmunity.人类自身免疫中的蛋白酪氨酸磷酸酶PTPN22
Autoimmunity. 2007 Sep;40(6):453-61. doi: 10.1080/08916930701464897.
7
Evaluation of the effects of chemically different linkers on hepatic accumulations, cell tropism and gene silencing ability of cholesterol-conjugated antisense oligonucleotides.评估化学结构不同的连接子对胆固醇偶联反义寡核苷酸的肝脏蓄积、细胞嗜性和基因沉默能力的影响。
J Control Release. 2016 Mar 28;226:57-65. doi: 10.1016/j.jconrel.2016.02.007. Epub 2016 Feb 5.
8
Suppression of protein tyrosine phosphatase PTPN22 gene induces apoptosis in T-cell leukemia cell line (Jurkat) through the AKT and ERK pathways.抑制蛋白酪氨酸磷酸酶 PTPN22 基因通过 AKT 和 ERK 通路诱导 T 细胞白血病细胞系(Jurkat)凋亡。
Biomed Pharmacother. 2017 Feb;86:41-47. doi: 10.1016/j.biopha.2016.11.124. Epub 2016 Dec 6.
9
Are other protein tyrosine phosphatases than PTPN22 associated with autoimmunity?除PTPN22外,其他蛋白酪氨酸磷酸酶是否与自身免疫有关?
Semin Immunol. 2006 Aug;18(4):254-60. doi: 10.1016/j.smim.2006.03.013. Epub 2006 May 5.
10
PTPN22/LYP 1858C>T gene polymorphism and susceptibility to endometriosis in a Polish population.波兰人群中PTPN22/LYP 1858C>T基因多态性与子宫内膜异位症易感性
J Reprod Immunol. 2009 Jan;79(2):196-200. doi: 10.1016/j.jri.2008.11.004. Epub 2009 Feb 23.

引用本文的文献

1
Modulating the Cellular Immune Response of Oligonucleotides by Brush Polymer-Assisted Compaction.通过刷状聚合物辅助紧缩调节寡核苷酸的细胞免疫反应。
Small. 2017 Nov;13(43). doi: 10.1002/smll.201701432. Epub 2017 Jul 11.
2
Use of short interfering RNA delivered by cationic liposomes to enable efficient down-regulation of PTPN22 gene in human T lymphocytes.使用阳离子脂质体递送的短干扰RNA实现人T淋巴细胞中PTPN22基因的有效下调。
PLoS One. 2017 Apr 24;12(4):e0175784. doi: 10.1371/journal.pone.0175784. eCollection 2017.
3
Evaluation of the immunological profile of antibody-functionalized metal-filled single-walled carbon nanocapsules for targeted radiotherapy.
评估抗体功能化金属填充单壁碳纳米胶囊的免疫特性,用于靶向放射治疗。
Sci Rep. 2017 Feb 15;7:42605. doi: 10.1038/srep42605.
4
Immune cell impact of three differently coated lipid nanocapsules: pluronic, chitosan and polyethylene glycol.三种不同涂层脂质纳米胶囊(普朗尼克、壳聚糖和聚乙二醇)对免疫细胞的影响
Sci Rep. 2016 Jan 5;6:18423. doi: 10.1038/srep18423.
5
Recent Advances in the Synthesis and Biomedical Applications of Nanocomposite Hydrogels.纳米复合水凝胶的合成及生物医学应用的最新进展。
Pharmaceutics. 2015 Oct 13;7(4):413-37. doi: 10.3390/pharmaceutics7040413.
6
Graphene as cancer theranostic tool: progress and future challenges.石墨烯作为癌症诊疗工具:进展与未来挑战。
Theranostics. 2015 Mar 28;5(7):710-23. doi: 10.7150/thno.11387. eCollection 2015.
7
Polyethylene-glycol-modified single-walled carbon nanotubes for intra-articular delivery to chondrocytes.用于向软骨细胞进行关节内递送的聚乙二醇修饰的单壁碳纳米管。
ACS Nano. 2014 Dec 23;8(12):12280-91. doi: 10.1021/nn504537b. Epub 2014 Nov 26.
8
Impact of carbon nanotubes and graphene on immune cells.碳纳米管和石墨烯对免疫细胞的影响。
J Transl Med. 2014 May 21;12:138. doi: 10.1186/1479-5876-12-138.
9
Application of carbon nanotubes layered on silicon wafer for the detection of breast cancer marker carbohydrate antigen 15-3 by immuno-polymerase chain reaction.硅片上碳纳米管的应用,用于通过免疫聚合酶链反应检测乳腺癌标志物糖类抗原15-3 。
J Mater Sci Mater Med. 2014 Jan;25(1):101-11. doi: 10.1007/s10856-013-5060-9. Epub 2013 Oct 1.
10
Functionalized multiwalled carbon nanotubes as ultrasound contrast agents.功能化多壁碳纳米管作为超声造影剂。
Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16612-7. doi: 10.1073/pnas.1208312109. Epub 2012 Sep 24.